High-efficacy DMTs are disease-modifying therapies that tend to reduce relapses and new MRI activity more strongly than older options. Examples include medications like ocrelizumab, ofatumumab, and natalizumab. They can have more involved monitoring because of how powerfully they act on the immune system.
You will hear this phrase when your team talks about starting with a stronger option up front. It helps explain why some treatment conversations compare medication strength, monitoring, and risk differently.
MS care is specialized — the center you choose shapes access to DMTs, infusions, and clinical trials. Pick your state to see centers in your area.
It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.